A randomized, double-blind trial from Johns Hopkins in 2016 found that a single dose of psilocybin substantially improved quality of life and decreased depression and anxiety in people with…
LSD
There’s a fair amount of excitement bubbling up over the potential for a market in psychedelics. Mostly, we’re hearing about psilocybin and psilocin, the active psychedelic components in magic…
Mind Medicine (MMED.E) has worked together with University Hospital Basel’s Liechti Laboratory to discover and file and patent application in the United States for a neutralizer technology that will…
Oxycontin, once pitched as a treatment for chronic pain, is now synonymous with the opioids currently plaguing Canada and the United States. In the U.S. alone, some estimates place…